Pluvo | $5,000,000 | (Mar 3, 2026)
Flux(US) | $27,000,000 | (Mar 3, 2026)
Multitude Insights | $10,000,000 | (Mar 3, 2026) Certified by Founder
Lodge
Procyrion, Inc.
start up
United States
- Houston, TX
- 06/02/2024
- Series E
- $57,700,000
Procyrion is dedicated to improving outcomes for patients with cardiac and renal impairment using its catheter-deployed pump technology to address conditions with significant unmet needs. Aortix™ is a percutaneous mechanical circulatory support device that treats cardiorenal syndrome with a rapidly-deployed intra-aortic catheter-based system.
Aortix™ is currently in the research and development phase and is not available for sale in any country.
(Caution: investigational device. Limited by federal law to investigational use.)
- Industry Medical Equipment Manufacturing
- Website https://www.procyrion.com/
- LinkedIn https://www.linkedin.com/company/procyrion/
Smack Technologies Inc. | $32,000,000 | (Mar 3, 2026)
Huper Corporation | $1,500,000 | (Mar 3, 2026)
Inhouse | $5,000,000 | (Mar 3, 2026)
Plurio by Elly Analytics | $3,500,000 | (Mar 3, 2026)
MeltPlan | $10,000,000 | (Mar 3, 2026)
Outpost Bio | $3,500,000 | (Mar 3, 2026)
SECONDSENSE | $2,000,000 | (Mar 3, 2026)
Ease Health | $41,000,000 | (Mar 3, 2026)